PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION Trademark

Trademark Overview


On Tuesday, March 22, 2016, a trademark application was filed for PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION with the United States Patent and Trademark Office. The USPTO has given the PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION trademark a serial number of 86949110. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, February 4, 2017. This trademark is owned by NPS Pharmaceuticals, Inc.. The PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia
preotact parathyroid hormone (rdna origin) for injection

General Information


Serial Number86949110
Word MarkPREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION
Filing DateTuesday, March 22, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, February 4, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PARATHYROID (RDNA ORIGIN) FOR INJECTION"
Description of MarkThe mark consists of the letters "PREOTACT" in uppercase letters above "parathyroid hormone (rDNA origin) for injection". Curved lines are behind and below the words.
Goods and ServicesPharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 28, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHIRE-NPS PHARMACEUTICALS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02421

Party NameNPS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Trademark Events


Event DateEvent Description
Monday, February 6, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, February 4, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 10, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 8, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 8, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 4, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 7, 2016NON-FINAL ACTION E-MAILED
Thursday, July 7, 2016NON-FINAL ACTION WRITTEN
Thursday, June 30, 2016ASSIGNED TO EXAMINER
Tuesday, March 29, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 25, 2016NEW APPLICATION ENTERED IN TRAM